User menu

Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).

Bibliographic reference Piessevaux, Hubert ; Buyse, M. ; De Roock, Wendy ; Prenen, H ; Schlichting, M ; et. al. Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).. In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 20, no. 8, p. 1375-82 (2009)
Permanent URL http://hdl.handle.net/2078.1/22465